nodes	percent_of_prediction	percent_of_DWPC	metapath
Metyrapone—ABCC3—Etoposide—uterine cancer	0.215	0.277	CbGbCtD
Metyrapone—CYP2A6—Progesterone—uterine cancer	0.213	0.274	CbGbCtD
Metyrapone—ABCC3—Doxorubicin—uterine cancer	0.146	0.189	CbGbCtD
Metyrapone—CYP3A4—Medroxyprogesterone Acetate—uterine cancer	0.0643	0.0829	CbGbCtD
Metyrapone—CYP2E1—Etoposide—uterine cancer	0.0629	0.0811	CbGbCtD
Metyrapone—CYP3A4—Progesterone—uterine cancer	0.0426	0.0549	CbGbCtD
Metyrapone—CYP3A4—Etoposide—uterine cancer	0.0191	0.0246	CbGbCtD
Metyrapone—CYP3A4—Doxorubicin—uterine cancer	0.013	0.0168	CbGbCtD
Metyrapone—CYP11B2—Glucocorticoid & Mineralcorticoid Metabolism—CYP11A1—uterine cancer	0.00933	0.0624	CbGpPWpGaD
Metyrapone—CYP11B2—Metabolism of steroid hormones and vitamin D—SRD5A2—uterine cancer	0.00694	0.0464	CbGpPWpGaD
Metyrapone—CYP11B1—Metabolism of steroid hormones and vitamin D—SRD5A2—uterine cancer	0.00598	0.04	CbGpPWpGaD
Metyrapone—Hirsutism—Progesterone—uterine cancer	0.00524	0.0702	CcSEcCtD
Metyrapone—CYP11B2—Metabolism of steroid hormones and vitamin D—AKR1B1—uterine cancer	0.00502	0.0336	CbGpPWpGaD
Metyrapone—CYP11B2—Metabolism of steroid hormones and vitamin D—STAR—uterine cancer	0.00502	0.0336	CbGpPWpGaD
Metyrapone—Hirsutism—Medroxyprogesterone Acetate—uterine cancer	0.00474	0.0636	CcSEcCtD
Metyrapone—CYP11B1—Metabolism of steroid hormones and vitamin D—AKR1B1—uterine cancer	0.00433	0.0289	CbGpPWpGaD
Metyrapone—CYP11B1—Metabolism of steroid hormones and vitamin D—STAR—uterine cancer	0.00433	0.0289	CbGpPWpGaD
Metyrapone—CYP11B2—Endogenous sterols—CYP11A1—uterine cancer	0.00401	0.0268	CbGpPWpGaD
Metyrapone—Endocrine disorder—Progesterone—uterine cancer	0.00367	0.0492	CcSEcCtD
Metyrapone—CYP11B1—Endogenous sterols—CYP11A1—uterine cancer	0.00346	0.0231	CbGpPWpGaD
Metyrapone—Endocrine disorder—Medroxyprogesterone Acetate—uterine cancer	0.00333	0.0446	CcSEcCtD
Metyrapone—CYP11B2—Metabolism of steroid hormones and vitamin D—CYP11A1—uterine cancer	0.003	0.0201	CbGpPWpGaD
Metyrapone—CYP11B2—Endogenous sterols—CYP19A1—uterine cancer	0.00295	0.0197	CbGpPWpGaD
Metyrapone—ABCC3—ABC-family proteins mediated transport—ABCC9—uterine cancer	0.00291	0.0194	CbGpPWpGaD
Metyrapone—CYP11B1—Metabolism of steroid hormones and vitamin D—CYP11A1—uterine cancer	0.00259	0.0173	CbGpPWpGaD
Metyrapone—CYP11B1—Endogenous sterols—CYP19A1—uterine cancer	0.00254	0.017	CbGpPWpGaD
Metyrapone—CYP2A6—Quercetin and Nf-kB/ AP-1 Induced Cell Apoptosis—NFE2L2—uterine cancer	0.00235	0.0157	CbGpPWpGaD
Metyrapone—CYP11B2—Metabolism of steroid hormones and vitamin D—CYP19A1—uterine cancer	0.00221	0.0148	CbGpPWpGaD
Metyrapone—ABCC3—Bile acid and bile salt metabolism—AKR1C1—uterine cancer	0.00213	0.0143	CbGpPWpGaD
Metyrapone—ABCC3—Fluoropyrimidine Activity—RRM2—uterine cancer	0.00204	0.0136	CbGpPWpGaD
Metyrapone—CYP11B1—Corticotropin-releasing hormone—STAR—uterine cancer	0.00191	0.0127	CbGpPWpGaD
Metyrapone—CYP11B1—Metabolism of steroid hormones and vitamin D—CYP19A1—uterine cancer	0.0019	0.0127	CbGpPWpGaD
Metyrapone—CYP11B2—Cytochrome P450 - arranged by substrate type—CYP11A1—uterine cancer	0.00186	0.0124	CbGpPWpGaD
Metyrapone—CYP11B2—Oxidation by Cytochrome P450—CYP11A1—uterine cancer	0.00184	0.0123	CbGpPWpGaD
Metyrapone—Abdominal discomfort—Progesterone—uterine cancer	0.00183	0.0245	CcSEcCtD
Metyrapone—Pain—Carboplatin—uterine cancer	0.00177	0.0237	CcSEcCtD
Metyrapone—Abdominal discomfort—Medroxyprogesterone Acetate—uterine cancer	0.00166	0.0222	CcSEcCtD
Metyrapone—ABCC3—Bile acid and bile salt metabolism—AKR1C3—uterine cancer	0.00164	0.011	CbGpPWpGaD
Metyrapone—CYP11B1—Cytochrome P450 - arranged by substrate type—CYP11A1—uterine cancer	0.0016	0.0107	CbGpPWpGaD
Metyrapone—CYP11B1—Oxidation by Cytochrome P450—CYP11A1—uterine cancer	0.00158	0.0106	CbGpPWpGaD
Metyrapone—CYP11B2—Phase 1 - Functionalization of compounds—CYP11A1—uterine cancer	0.00151	0.0101	CbGpPWpGaD
Metyrapone—CYP3A4—Benzo(a)pyrene metabolism—AKR1C1—uterine cancer	0.00148	0.00993	CbGpPWpGaD
Metyrapone—CYP2E1—Folate-Alcohol and Cancer Pathway—MTHFR—uterine cancer	0.00144	0.00964	CbGpPWpGaD
Metyrapone—CYP11B2—Metapathway biotransformation—AKR1B10—uterine cancer	0.00142	0.0095	CbGpPWpGaD
Metyrapone—Angiopathy—Progesterone—uterine cancer	0.00139	0.0186	CcSEcCtD
Metyrapone—CYP11B2—Cytochrome P450 - arranged by substrate type—CYP19A1—uterine cancer	0.00137	0.00916	CbGpPWpGaD
Metyrapone—CYP11B2—Oxidation by Cytochrome P450—CYP19A1—uterine cancer	0.00135	0.00904	CbGpPWpGaD
Metyrapone—Alopecia—Progesterone—uterine cancer	0.00135	0.0181	CcSEcCtD
Metyrapone—CYP11B2—Metapathway biotransformation—AKR1B1—uterine cancer	0.00132	0.00883	CbGpPWpGaD
Metyrapone—CYP11B1—Phase 1 - Functionalization of compounds—CYP11A1—uterine cancer	0.0013	0.0087	CbGpPWpGaD
Metyrapone—Bone marrow depression—Epirubicin—uterine cancer	0.00129	0.0173	CcSEcCtD
Metyrapone—Pancytopenia—Dactinomycin—uterine cancer	0.00128	0.0172	CcSEcCtD
Metyrapone—CYP2A6—Fluoropyrimidine Activity—RRM2—uterine cancer	0.00128	0.00853	CbGpPWpGaD
Metyrapone—Angiopathy—Medroxyprogesterone Acetate—uterine cancer	0.00126	0.0168	CcSEcCtD
Metyrapone—CYP11B1—Metapathway biotransformation—AKR1B10—uterine cancer	0.00123	0.00819	CbGpPWpGaD
Metyrapone—Alopecia—Medroxyprogesterone Acetate—uterine cancer	0.00122	0.0164	CcSEcCtD
Metyrapone—Bone marrow depression—Doxorubicin—uterine cancer	0.0012	0.016	CcSEcCtD
Metyrapone—CYP11B1—Cytochrome P450 - arranged by substrate type—CYP19A1—uterine cancer	0.00118	0.00789	CbGpPWpGaD
Metyrapone—Dermatitis atopic—Epirubicin—uterine cancer	0.00118	0.0158	CcSEcCtD
Metyrapone—CYP11B1—Oxidation by Cytochrome P450—CYP19A1—uterine cancer	0.00117	0.00779	CbGpPWpGaD
Metyrapone—Hypertension—Progesterone—uterine cancer	0.00115	0.0154	CcSEcCtD
Metyrapone—CYP3A4—Benzo(a)pyrene metabolism—AKR1C3—uterine cancer	0.00114	0.00764	CbGpPWpGaD
Metyrapone—CYP11B1—Corticotropin-releasing hormone—CYP11A1—uterine cancer	0.00114	0.00762	CbGpPWpGaD
Metyrapone—CYP11B1—Metapathway biotransformation—AKR1B1—uterine cancer	0.00114	0.00761	CbGpPWpGaD
Metyrapone—Unspecified disorder of skin and subcutaneous tissue—Progesterone—uterine cancer	0.00112	0.0151	CcSEcCtD
Metyrapone—CYP11B2—Phase 1 - Functionalization of compounds—CYP19A1—uterine cancer	0.00111	0.00742	CbGpPWpGaD
Metyrapone—Dermatitis atopic—Doxorubicin—uterine cancer	0.00109	0.0146	CcSEcCtD
Metyrapone—Nervous system disorder—Progesterone—uterine cancer	0.00106	0.0143	CcSEcCtD
Metyrapone—Skin disorder—Progesterone—uterine cancer	0.00105	0.0141	CcSEcCtD
Metyrapone—ABCC3—Fluoropyrimidine Activity—MTHFR—uterine cancer	0.00103	0.00689	CbGpPWpGaD
Metyrapone—Unspecified disorder of skin and subcutaneous tissue—Medroxyprogesterone Acetate—uterine cancer	0.00102	0.0137	CcSEcCtD
Metyrapone—Hypotension—Progesterone—uterine cancer	0.00101	0.0136	CcSEcCtD
Metyrapone—CYP11B2—Metapathway biotransformation—AKR1C1—uterine cancer	0.00097	0.00648	CbGpPWpGaD
Metyrapone—Nervous system disorder—Medroxyprogesterone Acetate—uterine cancer	0.000965	0.0129	CcSEcCtD
Metyrapone—CYP11B1—Phase 1 - Functionalization of compounds—CYP19A1—uterine cancer	0.000957	0.0064	CbGpPWpGaD
Metyrapone—Skin disorder—Medroxyprogesterone Acetate—uterine cancer	0.000956	0.0128	CcSEcCtD
Metyrapone—Alopecia—Dactinomycin—uterine cancer	0.000954	0.0128	CcSEcCtD
Metyrapone—Gastrointestinal disorder—Progesterone—uterine cancer	0.000937	0.0126	CcSEcCtD
Metyrapone—Pain—Progesterone—uterine cancer	0.000928	0.0124	CcSEcCtD
Metyrapone—Pancytopenia—Etoposide—uterine cancer	0.000927	0.0124	CcSEcCtD
Metyrapone—Hypotension—Medroxyprogesterone Acetate—uterine cancer	0.000919	0.0123	CcSEcCtD
Metyrapone—Gastrointestinal pain—Progesterone—uterine cancer	0.000888	0.0119	CcSEcCtD
Metyrapone—Abdominal pain—Progesterone—uterine cancer	0.000858	0.0115	CcSEcCtD
Metyrapone—CYP11B2—Metapathway biotransformation—GPX3—uterine cancer	0.000852	0.00569	CbGpPWpGaD
Metyrapone—Gastrointestinal disorder—Medroxyprogesterone Acetate—uterine cancer	0.000849	0.0114	CcSEcCtD
Metyrapone—CYP11B1—Metapathway biotransformation—AKR1C1—uterine cancer	0.000836	0.00559	CbGpPWpGaD
Metyrapone—Gastrointestinal pain—Medroxyprogesterone Acetate—uterine cancer	0.000804	0.0108	CcSEcCtD
Metyrapone—CYP11B2—Biological oxidations—CYP11A1—uterine cancer	0.000802	0.00536	CbGpPWpGaD
Metyrapone—CYP11B2—Metapathway biotransformation—CYP11A1—uterine cancer	0.000791	0.00529	CbGpPWpGaD
Metyrapone—Abdominal pain—Medroxyprogesterone Acetate—uterine cancer	0.000778	0.0104	CcSEcCtD
Metyrapone—CYP11B2—Metapathway biotransformation—AKR1C3—uterine cancer	0.000747	0.00499	CbGpPWpGaD
Metyrapone—CYP11B1—Metapathway biotransformation—GPX3—uterine cancer	0.000734	0.00491	CbGpPWpGaD
Metyrapone—CYP2A6—Cytochrome P450 - arranged by substrate type—CYP11A1—uterine cancer	0.000724	0.00484	CbGpPWpGaD
Metyrapone—Dizziness—Progesterone—uterine cancer	0.000718	0.00962	CcSEcCtD
Metyrapone—CYP2A6—Oxidation by Cytochrome P450—CYP11A1—uterine cancer	0.000714	0.00477	CbGpPWpGaD
Metyrapone—CYP11B2—Metabolism of lipids and lipoproteins—SRD5A2—uterine cancer	0.000712	0.00476	CbGpPWpGaD
Metyrapone—Angiopathy—Etoposide—uterine cancer	0.000709	0.00951	CcSEcCtD
Metyrapone—CYP11B1—Biological oxidations—CYP11A1—uterine cancer	0.000691	0.00462	CbGpPWpGaD
Metyrapone—Alopecia—Etoposide—uterine cancer	0.000691	0.00926	CcSEcCtD
Metyrapone—Vomiting—Progesterone—uterine cancer	0.00069	0.00925	CcSEcCtD
Metyrapone—CYP11B1—Metapathway biotransformation—CYP11A1—uterine cancer	0.000681	0.00456	CbGpPWpGaD
Metyrapone—Headache—Progesterone—uterine cancer	0.00068	0.00912	CcSEcCtD
Metyrapone—Pain—Dactinomycin—uterine cancer	0.000656	0.0088	CcSEcCtD
Metyrapone—Dizziness—Medroxyprogesterone Acetate—uterine cancer	0.000651	0.00872	CcSEcCtD
Metyrapone—CYP2A6—Fluoropyrimidine Activity—MTHFR—uterine cancer	0.000646	0.00432	CbGpPWpGaD
Metyrapone—Nausea—Progesterone—uterine cancer	0.000645	0.00865	CcSEcCtD
Metyrapone—CYP11B1—Metapathway biotransformation—AKR1C3—uterine cancer	0.000644	0.0043	CbGpPWpGaD
Metyrapone—ABCC3—NRF2 pathway—NFE2L2—uterine cancer	0.00064	0.00428	CbGpPWpGaD
Metyrapone—Gastrointestinal pain—Dactinomycin—uterine cancer	0.000627	0.00841	CcSEcCtD
Metyrapone—Vomiting—Medroxyprogesterone Acetate—uterine cancer	0.000625	0.00839	CcSEcCtD
Metyrapone—Headache—Medroxyprogesterone Acetate—uterine cancer	0.000616	0.00826	CcSEcCtD
Metyrapone—CYP11B1—Metabolism of lipids and lipoproteins—SRD5A2—uterine cancer	0.000613	0.0041	CbGpPWpGaD
Metyrapone—ABCC3—NRF2 pathway—GPX3—uterine cancer	0.000611	0.00408	CbGpPWpGaD
Metyrapone—Abdominal pain—Dactinomycin—uterine cancer	0.000607	0.00813	CcSEcCtD
Metyrapone—CYP11B2—Biological oxidations—CYP19A1—uterine cancer	0.00059	0.00394	CbGpPWpGaD
Metyrapone—Hypertension—Etoposide—uterine cancer	0.000588	0.00788	CcSEcCtD
Metyrapone—CYP2A6—Phase 1 - Functionalization of compounds—CYP11A1—uterine cancer	0.000587	0.00392	CbGpPWpGaD
Metyrapone—Nausea—Medroxyprogesterone Acetate—uterine cancer	0.000584	0.00783	CcSEcCtD
Metyrapone—CYP11B2—Metapathway biotransformation—CYP19A1—uterine cancer	0.000582	0.00389	CbGpPWpGaD
Metyrapone—CYP2A6—Quercetin and Nf-kB/ AP-1 Induced Cell Apoptosis—VEGFA—uterine cancer	0.000579	0.00387	CbGpPWpGaD
Metyrapone—Unspecified disorder of skin and subcutaneous tissue—Etoposide—uterine cancer	0.000575	0.00771	CcSEcCtD
Metyrapone—CYP2E1—Cytochrome P450 - arranged by substrate type—CYP11A1—uterine cancer	0.000572	0.00382	CbGpPWpGaD
Metyrapone—CYP2E1—Oxidation by Cytochrome P450—CYP11A1—uterine cancer	0.000564	0.00377	CbGpPWpGaD
Metyrapone—Skin disorder—Etoposide—uterine cancer	0.000539	0.00723	CcSEcCtD
Metyrapone—CYP2A6—Cytochrome P450 - arranged by substrate type—CYP19A1—uterine cancer	0.000532	0.00356	CbGpPWpGaD
Metyrapone—CYP2A6—Oxidation by Cytochrome P450—CYP19A1—uterine cancer	0.000526	0.00351	CbGpPWpGaD
Metyrapone—CYP2E1—Tryptophan metabolism—CYP19A1—uterine cancer	0.00052	0.00348	CbGpPWpGaD
Metyrapone—Pancytopenia—Epirubicin—uterine cancer	0.00052	0.00697	CcSEcCtD
Metyrapone—Hypotension—Etoposide—uterine cancer	0.000519	0.00696	CcSEcCtD
Metyrapone—CYP11B2—Metabolism of lipids and lipoproteins—STAR—uterine cancer	0.000515	0.00344	CbGpPWpGaD
Metyrapone—CYP11B2—Metabolism of lipids and lipoproteins—AKR1B1—uterine cancer	0.000515	0.00344	CbGpPWpGaD
Metyrapone—CYP11B1—Biological oxidations—CYP19A1—uterine cancer	0.000508	0.0034	CbGpPWpGaD
Metyrapone—CYP11B1—Metapathway biotransformation—CYP19A1—uterine cancer	0.000501	0.00335	CbGpPWpGaD
Metyrapone—Vomiting—Dactinomycin—uterine cancer	0.000488	0.00654	CcSEcCtD
Metyrapone—Pancytopenia—Doxorubicin—uterine cancer	0.000481	0.00645	CcSEcCtD
Metyrapone—Gastrointestinal disorder—Etoposide—uterine cancer	0.000479	0.00643	CcSEcCtD
Metyrapone—Pain—Etoposide—uterine cancer	0.000475	0.00637	CcSEcCtD
Metyrapone—CYP2E1—Phase 1 - Functionalization of compounds—CYP11A1—uterine cancer	0.000464	0.0031	CbGpPWpGaD
Metyrapone—Nausea—Dactinomycin—uterine cancer	0.000456	0.00611	CcSEcCtD
Metyrapone—Gastrointestinal pain—Etoposide—uterine cancer	0.000454	0.00609	CcSEcCtD
Metyrapone—CYP11B1—Metabolism of lipids and lipoproteins—AKR1B1—uterine cancer	0.000443	0.00296	CbGpPWpGaD
Metyrapone—CYP11B1—Metabolism of lipids and lipoproteins—STAR—uterine cancer	0.000443	0.00296	CbGpPWpGaD
Metyrapone—ABCC3—Metabolism of lipids and lipoproteins—SRD5A2—uterine cancer	0.000442	0.00295	CbGpPWpGaD
Metyrapone—Abdominal pain—Etoposide—uterine cancer	0.000439	0.00589	CcSEcCtD
Metyrapone—CYP2E1—Metapathway biotransformation—AKR1B10—uterine cancer	0.000437	0.00292	CbGpPWpGaD
Metyrapone—CYP2A6—Phase 1 - Functionalization of compounds—CYP19A1—uterine cancer	0.000432	0.00289	CbGpPWpGaD
Metyrapone—CYP2E1—Cytochrome P450 - arranged by substrate type—CYP19A1—uterine cancer	0.000421	0.00281	CbGpPWpGaD
Metyrapone—CYP2E1—Oxidation by Cytochrome P450—CYP19A1—uterine cancer	0.000415	0.00278	CbGpPWpGaD
Metyrapone—CYP2E1—Metapathway biotransformation—AKR1B1—uterine cancer	0.000406	0.00271	CbGpPWpGaD
Metyrapone—CYP2A6—NRF2 pathway—NFE2L2—uterine cancer	0.000401	0.00268	CbGpPWpGaD
Metyrapone—Angiopathy—Epirubicin—uterine cancer	0.000398	0.00533	CcSEcCtD
Metyrapone—ABCC3—Fluoropyrimidine Activity—TP53—uterine cancer	0.000391	0.00262	CbGpPWpGaD
Metyrapone—CYP11B1—Corticotropin-releasing hormone—CXCL8—uterine cancer	0.00039	0.00261	CbGpPWpGaD
Metyrapone—Alopecia—Epirubicin—uterine cancer	0.000387	0.00519	CcSEcCtD
Metyrapone—CYP2A6—NRF2 pathway—GPX3—uterine cancer	0.000383	0.00256	CbGpPWpGaD
Metyrapone—CYP11B2—Metabolism of lipids and lipoproteins—AKR1C1—uterine cancer	0.000378	0.00252	CbGpPWpGaD
Metyrapone—Angiopathy—Doxorubicin—uterine cancer	0.000368	0.00493	CcSEcCtD
Metyrapone—Dizziness—Etoposide—uterine cancer	0.000367	0.00492	CcSEcCtD
Metyrapone—CYP11B1—Corticotropin-releasing hormone—CTNNB1—uterine cancer	0.00036	0.0024	CbGpPWpGaD
Metyrapone—Alopecia—Doxorubicin—uterine cancer	0.000358	0.0048	CcSEcCtD
Metyrapone—Vomiting—Etoposide—uterine cancer	0.000353	0.00473	CcSEcCtD
Metyrapone—Headache—Etoposide—uterine cancer	0.000348	0.00466	CcSEcCtD
Metyrapone—CYP2E1—Phase 1 - Functionalization of compounds—CYP19A1—uterine cancer	0.000341	0.00228	CbGpPWpGaD
Metyrapone—Nausea—Etoposide—uterine cancer	0.00033	0.00442	CcSEcCtD
Metyrapone—Hypertension—Epirubicin—uterine cancer	0.000329	0.00442	CcSEcCtD
Metyrapone—CYP11B1—Metabolism of lipids and lipoproteins—AKR1C1—uterine cancer	0.000325	0.00218	CbGpPWpGaD
Metyrapone—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—uterine cancer	0.000323	0.00432	CcSEcCtD
Metyrapone—ABCC3—Metabolism of lipids and lipoproteins—STAR—uterine cancer	0.000319	0.00213	CbGpPWpGaD
Metyrapone—ABCC3—Metabolism of lipids and lipoproteins—AKR1B1—uterine cancer	0.000319	0.00213	CbGpPWpGaD
Metyrapone—CYP11B2—Metabolism—NDUFB11—uterine cancer	0.000317	0.00212	CbGpPWpGaD
Metyrapone—CYP11B2—Metabolism—SRD5A2—uterine cancer	0.000317	0.00212	CbGpPWpGaD
Metyrapone—CYP2A6—Biological oxidations—CYP11A1—uterine cancer	0.000312	0.00208	CbGpPWpGaD
Metyrapone—CYP11B2—Metabolism of lipids and lipoproteins—CYP11A1—uterine cancer	0.000308	0.00206	CbGpPWpGaD
Metyrapone—Nervous system disorder—Epirubicin—uterine cancer	0.000305	0.00409	CcSEcCtD
Metyrapone—Hypertension—Doxorubicin—uterine cancer	0.000305	0.00409	CcSEcCtD
Metyrapone—ABCC3—Transmembrane transport of small molecules—ABCC9—uterine cancer	0.000304	0.00203	CbGpPWpGaD
Metyrapone—Skin disorder—Epirubicin—uterine cancer	0.000302	0.00405	CcSEcCtD
Metyrapone—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—uterine cancer	0.000298	0.004	CcSEcCtD
Metyrapone—CYP2E1—Metapathway biotransformation—AKR1C1—uterine cancer	0.000298	0.00199	CbGpPWpGaD
Metyrapone—Hypotension—Epirubicin—uterine cancer	0.000291	0.0039	CcSEcCtD
Metyrapone—CYP11B2—Metabolism of lipids and lipoproteins—AKR1C3—uterine cancer	0.000291	0.00194	CbGpPWpGaD
Metyrapone—Nervous system disorder—Doxorubicin—uterine cancer	0.000282	0.00379	CcSEcCtD
Metyrapone—Skin disorder—Doxorubicin—uterine cancer	0.00028	0.00375	CcSEcCtD
Metyrapone—CYP11B1—Metabolism—SRD5A2—uterine cancer	0.000273	0.00183	CbGpPWpGaD
Metyrapone—CYP11B1—Metabolism—NDUFB11—uterine cancer	0.000273	0.00183	CbGpPWpGaD
Metyrapone—Hypotension—Doxorubicin—uterine cancer	0.000269	0.00361	CcSEcCtD
Metyrapone—Gastrointestinal disorder—Epirubicin—uterine cancer	0.000269	0.0036	CcSEcCtD
Metyrapone—Pain—Epirubicin—uterine cancer	0.000266	0.00357	CcSEcCtD
Metyrapone—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP11A1—uterine cancer	0.000265	0.00177	CbGpPWpGaD
Metyrapone—CYP11B1—Metabolism of lipids and lipoproteins—CYP11A1—uterine cancer	0.000265	0.00177	CbGpPWpGaD
Metyrapone—CYP3A4—Oxidation by Cytochrome P450—CYP11A1—uterine cancer	0.000262	0.00175	CbGpPWpGaD
Metyrapone—CYP2E1—Metapathway biotransformation—GPX3—uterine cancer	0.000262	0.00175	CbGpPWpGaD
Metyrapone—Gastrointestinal pain—Epirubicin—uterine cancer	0.000255	0.00341	CcSEcCtD
Metyrapone—CYP11B1—Metabolism of lipids and lipoproteins—AKR1C3—uterine cancer	0.000251	0.00167	CbGpPWpGaD
Metyrapone—Gastrointestinal disorder—Doxorubicin—uterine cancer	0.000249	0.00333	CcSEcCtD
Metyrapone—Pain—Doxorubicin—uterine cancer	0.000246	0.0033	CcSEcCtD
Metyrapone—CYP2E1—Biological oxidations—CYP11A1—uterine cancer	0.000246	0.00165	CbGpPWpGaD
Metyrapone—Abdominal pain—Epirubicin—uterine cancer	0.000246	0.0033	CcSEcCtD
Metyrapone—CYP2A6—Fluoropyrimidine Activity—TP53—uterine cancer	0.000245	0.00164	CbGpPWpGaD
Metyrapone—CYP2E1—Metapathway biotransformation—CYP11A1—uterine cancer	0.000243	0.00162	CbGpPWpGaD
Metyrapone—CYP3A4—Tryptophan metabolism—CYP19A1—uterine cancer	0.000241	0.00161	CbGpPWpGaD
Metyrapone—Gastrointestinal pain—Doxorubicin—uterine cancer	0.000236	0.00316	CcSEcCtD
Metyrapone—ABCC3—Metabolism of lipids and lipoproteins—AKR1C1—uterine cancer	0.000234	0.00157	CbGpPWpGaD
Metyrapone—CYP2E1—Metapathway biotransformation—AKR1C3—uterine cancer	0.000229	0.00153	CbGpPWpGaD
Metyrapone—CYP2A6—Biological oxidations—CYP19A1—uterine cancer	0.000229	0.00153	CbGpPWpGaD
Metyrapone—CYP11B2—Metabolism—AKR1B1—uterine cancer	0.000229	0.00153	CbGpPWpGaD
Metyrapone—CYP11B2—Metabolism—STAR—uterine cancer	0.000229	0.00153	CbGpPWpGaD
Metyrapone—Abdominal pain—Doxorubicin—uterine cancer	0.000228	0.00305	CcSEcCtD
Metyrapone—CYP11B2—Metabolism of lipids and lipoproteins—CYP19A1—uterine cancer	0.000227	0.00151	CbGpPWpGaD
Metyrapone—CYP3A4—Phase 1 - Functionalization of compounds—CYP11A1—uterine cancer	0.000215	0.00144	CbGpPWpGaD
Metyrapone—Dizziness—Epirubicin—uterine cancer	0.000206	0.00276	CcSEcCtD
Metyrapone—CYP3A4—Metapathway biotransformation—AKR1B10—uterine cancer	0.000203	0.00135	CbGpPWpGaD
Metyrapone—CYP11B1—Corticotropin-releasing hormone—AKT1—uterine cancer	0.000202	0.00135	CbGpPWpGaD
Metyrapone—Vomiting—Epirubicin—uterine cancer	0.000198	0.00265	CcSEcCtD
Metyrapone—CYP11B1—Metabolism—AKR1B1—uterine cancer	0.000197	0.00132	CbGpPWpGaD
Metyrapone—CYP11B1—Metabolism—STAR—uterine cancer	0.000197	0.00132	CbGpPWpGaD
Metyrapone—ABCC3—Metabolism—NDUFB11—uterine cancer	0.000197	0.00131	CbGpPWpGaD
Metyrapone—ABCC3—Metabolism—SRD5A2—uterine cancer	0.000197	0.00131	CbGpPWpGaD
Metyrapone—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP19A1—uterine cancer	0.000195	0.00131	CbGpPWpGaD
Metyrapone—CYP11B1—Metabolism of lipids and lipoproteins—CYP19A1—uterine cancer	0.000195	0.0013	CbGpPWpGaD
Metyrapone—Headache—Epirubicin—uterine cancer	0.000195	0.00261	CcSEcCtD
Metyrapone—CYP3A4—Oxidation by Cytochrome P450—CYP19A1—uterine cancer	0.000193	0.00129	CbGpPWpGaD
Metyrapone—ABCC3—Metabolism of lipids and lipoproteins—CYP11A1—uterine cancer	0.000191	0.00128	CbGpPWpGaD
Metyrapone—Dizziness—Doxorubicin—uterine cancer	0.00019	0.00255	CcSEcCtD
Metyrapone—CYP3A4—Metapathway biotransformation—AKR1B1—uterine cancer	0.000188	0.00126	CbGpPWpGaD
Metyrapone—Nausea—Epirubicin—uterine cancer	0.000185	0.00248	CcSEcCtD
Metyrapone—Vomiting—Doxorubicin—uterine cancer	0.000183	0.00246	CcSEcCtD
Metyrapone—CYP2E1—Biological oxidations—CYP19A1—uterine cancer	0.000181	0.00121	CbGpPWpGaD
Metyrapone—Headache—Doxorubicin—uterine cancer	0.00018	0.00242	CcSEcCtD
Metyrapone—ABCC3—Metabolism of lipids and lipoproteins—AKR1C3—uterine cancer	0.00018	0.00121	CbGpPWpGaD
Metyrapone—CYP11B2—Metabolism—POLD1—uterine cancer	0.00018	0.0012	CbGpPWpGaD
Metyrapone—CYP2E1—Metapathway biotransformation—CYP19A1—uterine cancer	0.000179	0.00119	CbGpPWpGaD
Metyrapone—Nausea—Doxorubicin—uterine cancer	0.000171	0.00229	CcSEcCtD
Metyrapone—CYP11B2—Metabolism—AKR1C1—uterine cancer	0.000168	0.00112	CbGpPWpGaD
Metyrapone—CYP3A4—Phase 1 - Functionalization of compounds—CYP19A1—uterine cancer	0.000158	0.00106	CbGpPWpGaD
Metyrapone—CYP11B1—Metabolism—POLD1—uterine cancer	0.000155	0.00104	CbGpPWpGaD
Metyrapone—CYP11B2—Metabolism—RRM2—uterine cancer	0.00015	0.001	CbGpPWpGaD
Metyrapone—CYP11B2—Metabolism—DCN—uterine cancer	0.000146	0.000973	CbGpPWpGaD
Metyrapone—CYP11B1—Metabolism—AKR1C1—uterine cancer	0.000145	0.000969	CbGpPWpGaD
Metyrapone—ABCC3—Metabolism—AKR1B1—uterine cancer	0.000142	0.000951	CbGpPWpGaD
Metyrapone—ABCC3—Metabolism—STAR—uterine cancer	0.000142	0.000951	CbGpPWpGaD
Metyrapone—ABCC3—Metabolism of lipids and lipoproteins—CYP19A1—uterine cancer	0.000141	0.00094	CbGpPWpGaD
Metyrapone—CYP3A4—Metapathway biotransformation—AKR1C1—uterine cancer	0.000138	0.000924	CbGpPWpGaD
Metyrapone—CYP11B2—Metabolism—CYP11A1—uterine cancer	0.000137	0.000917	CbGpPWpGaD
Metyrapone—CYP11B2—Metabolism—AKR1C3—uterine cancer	0.000129	0.000866	CbGpPWpGaD
Metyrapone—CYP11B1—Metabolism—RRM2—uterine cancer	0.000129	0.000864	CbGpPWpGaD
Metyrapone—CYP11B1—Metabolism—DCN—uterine cancer	0.000125	0.000838	CbGpPWpGaD
Metyrapone—CYP2A6—Metabolism—SRD5A2—uterine cancer	0.000123	0.000824	CbGpPWpGaD
Metyrapone—CYP2A6—Metabolism—NDUFB11—uterine cancer	0.000123	0.000824	CbGpPWpGaD
Metyrapone—CYP3A4—Metapathway biotransformation—GPX3—uterine cancer	0.000121	0.000811	CbGpPWpGaD
Metyrapone—CYP11B1—Metabolism—CYP11A1—uterine cancer	0.000118	0.00079	CbGpPWpGaD
Metyrapone—CYP3A4—Biological oxidations—CYP11A1—uterine cancer	0.000114	0.000764	CbGpPWpGaD
Metyrapone—CYP3A4—Metapathway biotransformation—CYP11A1—uterine cancer	0.000113	0.000753	CbGpPWpGaD
Metyrapone—CYP11B1—Metabolism—AKR1C3—uterine cancer	0.000112	0.000746	CbGpPWpGaD
Metyrapone—ABCC3—Metabolism—POLD1—uterine cancer	0.000112	0.000746	CbGpPWpGaD
Metyrapone—CYP3A4—Metapathway biotransformation—AKR1C3—uterine cancer	0.000106	0.000711	CbGpPWpGaD
Metyrapone—ABCC3—Metabolism—AKR1C1—uterine cancer	0.000104	0.000698	CbGpPWpGaD
Metyrapone—CYP11B2—Metabolism—CYP19A1—uterine cancer	0.000101	0.000674	CbGpPWpGaD
Metyrapone—CYP11B2—Metabolism—STK11—uterine cancer	0.000101	0.000674	CbGpPWpGaD
Metyrapone—CYP2E1—Metabolism—SRD5A2—uterine cancer	9.74e-05	0.000651	CbGpPWpGaD
Metyrapone—CYP2E1—Metabolism—NDUFB11—uterine cancer	9.74e-05	0.000651	CbGpPWpGaD
Metyrapone—CYP11B2—Metabolism of lipids and lipoproteins—PTEN—uterine cancer	9.47e-05	0.000633	CbGpPWpGaD
Metyrapone—ABCC3—Metabolism—RRM2—uterine cancer	9.3e-05	0.000622	CbGpPWpGaD
Metyrapone—ABCC3—Metabolism—DCN—uterine cancer	9.03e-05	0.000604	CbGpPWpGaD
Metyrapone—CYP11B2—Metabolism of lipids and lipoproteins—EP300—uterine cancer	9.03e-05	0.000604	CbGpPWpGaD
Metyrapone—CYP2A6—Metabolism—AKR1B1—uterine cancer	8.91e-05	0.000595	CbGpPWpGaD
Metyrapone—CYP2A6—Metabolism—STAR—uterine cancer	8.91e-05	0.000595	CbGpPWpGaD
Metyrapone—CYP11B1—Metabolism—STK11—uterine cancer	8.69e-05	0.000581	CbGpPWpGaD
Metyrapone—CYP11B1—Metabolism—CYP19A1—uterine cancer	8.69e-05	0.000581	CbGpPWpGaD
Metyrapone—ABCC3—Metabolism—CYP11A1—uterine cancer	8.51e-05	0.000569	CbGpPWpGaD
Metyrapone—CYP3A4—Biological oxidations—CYP19A1—uterine cancer	8.41e-05	0.000562	CbGpPWpGaD
Metyrapone—CYP3A4—Metapathway biotransformation—CYP19A1—uterine cancer	8.29e-05	0.000554	CbGpPWpGaD
Metyrapone—CYP11B1—Metabolism of lipids and lipoproteins—PTEN—uterine cancer	8.16e-05	0.000546	CbGpPWpGaD
Metyrapone—ABCC3—Metabolism—AKR1C3—uterine cancer	8.04e-05	0.000537	CbGpPWpGaD
Metyrapone—CYP11B1—Metabolism of lipids and lipoproteins—EP300—uterine cancer	7.78e-05	0.00052	CbGpPWpGaD
Metyrapone—CYP11B2—Metabolism—MTHFR—uterine cancer	7.58e-05	0.000507	CbGpPWpGaD
Metyrapone—CYP2E1—Metabolism—AKR1B1—uterine cancer	7.04e-05	0.000471	CbGpPWpGaD
Metyrapone—CYP2E1—Metabolism—STAR—uterine cancer	7.04e-05	0.000471	CbGpPWpGaD
Metyrapone—CYP2A6—Metabolism—POLD1—uterine cancer	6.99e-05	0.000467	CbGpPWpGaD
Metyrapone—CYP11B2—Metabolism of lipids and lipoproteins—PIK3CA—uterine cancer	6.68e-05	0.000447	CbGpPWpGaD
Metyrapone—CYP2A6—Metabolism—AKR1C1—uterine cancer	6.54e-05	0.000437	CbGpPWpGaD
Metyrapone—CYP11B1—Metabolism—MTHFR—uterine cancer	6.53e-05	0.000437	CbGpPWpGaD
Metyrapone—ABCC3—Metabolism—CYP19A1—uterine cancer	6.26e-05	0.000418	CbGpPWpGaD
Metyrapone—ABCC3—Metabolism—STK11—uterine cancer	6.26e-05	0.000418	CbGpPWpGaD
Metyrapone—ABCC3—Metabolism of lipids and lipoproteins—PTEN—uterine cancer	5.88e-05	0.000393	CbGpPWpGaD
Metyrapone—CYP2A6—Metabolism—RRM2—uterine cancer	5.83e-05	0.00039	CbGpPWpGaD
Metyrapone—CYP11B1—Metabolism of lipids and lipoproteins—PIK3CA—uterine cancer	5.76e-05	0.000385	CbGpPWpGaD
Metyrapone—CYP2A6—Metabolism—DCN—uterine cancer	5.66e-05	0.000378	CbGpPWpGaD
Metyrapone—ABCC3—Metabolism of lipids and lipoproteins—EP300—uterine cancer	5.6e-05	0.000375	CbGpPWpGaD
Metyrapone—CYP2E1—Metabolism—POLD1—uterine cancer	5.52e-05	0.000369	CbGpPWpGaD
Metyrapone—CYP2A6—Metabolism—CYP11A1—uterine cancer	5.33e-05	0.000356	CbGpPWpGaD
Metyrapone—CYP2E1—Metabolism—AKR1C1—uterine cancer	5.17e-05	0.000345	CbGpPWpGaD
Metyrapone—CYP2A6—Metabolism—AKR1C3—uterine cancer	5.03e-05	0.000336	CbGpPWpGaD
Metyrapone—ABCC3—Metabolism—MTHFR—uterine cancer	4.7e-05	0.000314	CbGpPWpGaD
Metyrapone—CYP2E1—Metabolism—RRM2—uterine cancer	4.61e-05	0.000308	CbGpPWpGaD
Metyrapone—CYP3A4—Metabolism—SRD5A2—uterine cancer	4.52e-05	0.000302	CbGpPWpGaD
Metyrapone—CYP3A4—Metabolism—NDUFB11—uterine cancer	4.52e-05	0.000302	CbGpPWpGaD
Metyrapone—CYP2E1—Metabolism—DCN—uterine cancer	4.47e-05	0.000299	CbGpPWpGaD
Metyrapone—CYP11B2—Metabolism—PTEN—uterine cancer	4.22e-05	0.000282	CbGpPWpGaD
Metyrapone—CYP2E1—Metabolism—CYP11A1—uterine cancer	4.21e-05	0.000282	CbGpPWpGaD
Metyrapone—ABCC3—Metabolism of lipids and lipoproteins—PIK3CA—uterine cancer	4.15e-05	0.000277	CbGpPWpGaD
Metyrapone—CYP11B2—Metabolism—EP300—uterine cancer	4.02e-05	0.000269	CbGpPWpGaD
Metyrapone—CYP2E1—Metabolism—AKR1C3—uterine cancer	3.98e-05	0.000266	CbGpPWpGaD
Metyrapone—CYP2A6—Metabolism—CYP19A1—uterine cancer	3.92e-05	0.000262	CbGpPWpGaD
Metyrapone—CYP2A6—Metabolism—STK11—uterine cancer	3.92e-05	0.000262	CbGpPWpGaD
Metyrapone—CYP11B1—Metabolism—PTEN—uterine cancer	3.63e-05	0.000243	CbGpPWpGaD
Metyrapone—CYP11B1—Metabolism—EP300—uterine cancer	3.47e-05	0.000232	CbGpPWpGaD
Metyrapone—CYP3A4—Metabolism—AKR1B1—uterine cancer	3.27e-05	0.000218	CbGpPWpGaD
Metyrapone—CYP3A4—Metabolism—STAR—uterine cancer	3.27e-05	0.000218	CbGpPWpGaD
Metyrapone—CYP2E1—Metabolism—STK11—uterine cancer	3.1e-05	0.000207	CbGpPWpGaD
Metyrapone—CYP2E1—Metabolism—CYP19A1—uterine cancer	3.1e-05	0.000207	CbGpPWpGaD
Metyrapone—CYP11B2—Metabolism—PIK3CA—uterine cancer	2.98e-05	0.000199	CbGpPWpGaD
Metyrapone—CYP2A6—Metabolism—MTHFR—uterine cancer	2.95e-05	0.000197	CbGpPWpGaD
Metyrapone—ABCC3—Metabolism—PTEN—uterine cancer	2.62e-05	0.000175	CbGpPWpGaD
Metyrapone—CYP11B1—Metabolism—PIK3CA—uterine cancer	2.56e-05	0.000171	CbGpPWpGaD
Metyrapone—CYP3A4—Metabolism—POLD1—uterine cancer	2.56e-05	0.000171	CbGpPWpGaD
Metyrapone—ABCC3—Metabolism—EP300—uterine cancer	2.5e-05	0.000167	CbGpPWpGaD
Metyrapone—CYP11B2—Metabolism—AKT1—uterine cancer	2.43e-05	0.000162	CbGpPWpGaD
Metyrapone—CYP3A4—Metabolism—AKR1C1—uterine cancer	2.4e-05	0.00016	CbGpPWpGaD
Metyrapone—CYP2E1—Metabolism—MTHFR—uterine cancer	2.33e-05	0.000156	CbGpPWpGaD
Metyrapone—CYP3A4—Metabolism—RRM2—uterine cancer	2.14e-05	0.000143	CbGpPWpGaD
Metyrapone—CYP11B1—Metabolism—AKT1—uterine cancer	2.09e-05	0.00014	CbGpPWpGaD
Metyrapone—CYP3A4—Metabolism—DCN—uterine cancer	2.07e-05	0.000139	CbGpPWpGaD
Metyrapone—CYP3A4—Metabolism—CYP11A1—uterine cancer	1.95e-05	0.000131	CbGpPWpGaD
Metyrapone—ABCC3—Metabolism—PIK3CA—uterine cancer	1.85e-05	0.000123	CbGpPWpGaD
Metyrapone—CYP3A4—Metabolism—AKR1C3—uterine cancer	1.85e-05	0.000123	CbGpPWpGaD
Metyrapone—CYP2A6—Metabolism—PTEN—uterine cancer	1.64e-05	0.00011	CbGpPWpGaD
Metyrapone—CYP2A6—Metabolism—EP300—uterine cancer	1.56e-05	0.000105	CbGpPWpGaD
Metyrapone—ABCC3—Metabolism—AKT1—uterine cancer	1.51e-05	0.000101	CbGpPWpGaD
Metyrapone—CYP3A4—Metabolism—STK11—uterine cancer	1.44e-05	9.61e-05	CbGpPWpGaD
Metyrapone—CYP3A4—Metabolism—CYP19A1—uterine cancer	1.44e-05	9.61e-05	CbGpPWpGaD
Metyrapone—CYP2E1—Metabolism—PTEN—uterine cancer	1.3e-05	8.66e-05	CbGpPWpGaD
Metyrapone—CYP2E1—Metabolism—EP300—uterine cancer	1.24e-05	8.26e-05	CbGpPWpGaD
Metyrapone—CYP2A6—Metabolism—PIK3CA—uterine cancer	1.16e-05	7.73e-05	CbGpPWpGaD
Metyrapone—CYP3A4—Metabolism—MTHFR—uterine cancer	1.08e-05	7.22e-05	CbGpPWpGaD
Metyrapone—CYP2A6—Metabolism—AKT1—uterine cancer	9.45e-06	6.32e-05	CbGpPWpGaD
Metyrapone—CYP2E1—Metabolism—PIK3CA—uterine cancer	9.14e-06	6.11e-05	CbGpPWpGaD
Metyrapone—CYP2E1—Metabolism—AKT1—uterine cancer	7.47e-06	4.99e-05	CbGpPWpGaD
Metyrapone—CYP3A4—Metabolism—PTEN—uterine cancer	6.01e-06	4.02e-05	CbGpPWpGaD
Metyrapone—CYP3A4—Metabolism—EP300—uterine cancer	5.73e-06	3.83e-05	CbGpPWpGaD
Metyrapone—CYP3A4—Metabolism—PIK3CA—uterine cancer	4.24e-06	2.83e-05	CbGpPWpGaD
Metyrapone—CYP3A4—Metabolism—AKT1—uterine cancer	3.46e-06	2.32e-05	CbGpPWpGaD
